The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
Download Sample Papers of Infectious Disease Diagnostics Market spread across 170 Pages, Profiling 12 Companies and Supported with 85 Tables and 35 Figures is now available at www.reportsnreports.com/contacts/r….aspx?name=323163 .
The infectious disease diagnostics market in this report is segmented by product& service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches& approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
1 Market Overview
2 Market Ranking Analysis, 2017
3 Competitive Situation and Trends
4 Product Launches and Approvals
5 Collaborations, Agreements, and Partnerships
Infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software.
The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out.
Click Here for More Information on Infectious Disease Diagnostics Market with Forecast and Company Profiles at www.reportsnreports.com/contacts/i….aspx?name=323163 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
- Orthodontic product manufacturers, vendors, and distributors
- Venture capitalists and other government funding organizations
- Healthcare service providers (including hospitals and dental & orthodontic clinics)
- Research laboratories
- Academic institutes
- Market research and consultancy firms
- Government and independent regulatory authorities
Key players in infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, collaborations and as well as organic strategies such as expansions and product launches & approvals to sustain their growth in the market.
Connect for More Details for More Information “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022” report at www.reportsnreports.com/contacts/d….aspx?name=323163 .
The infectious disease diagnostics market is segmented into major seven technologies, namely, immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarrays, and other technologies. In 2017, the immunodiagnostics segment accounted for the largest share of the global market.
Global infectious disease diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, physician offices, academic/research institutes, and other end users. In 2017, the hospitals/clinical laboratories segment accounted for the largest share of the global market.
Also, this segment is expected to grow at the highest CAGR during the forecast period due to the large number of diagnostic tests carried out in hospitals.